Global Gastrointestinal Drugs Market | CAGR 5.20%

The Global Gastrointestinal Drugs Market to grow from USD 42,567.55 Million in 2018 to USD 60,705.25 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.20%. Some of the major market players include AbbVie Inc., Abbott Laboratories, AstraZeneca plc, Bausch Health Companies Inc., and Johnson & Johnson.

360iResearch Logo
Global Gastrointestinal Drugs Market | CAGR 5.20%
Report Code: PH-DA051D2 | Publishing Date: August 2019 | Number of Pages: 104
Global Gastrointestinal Drugs Market | CAGR 5.20%

Company Usability Profiles:

The global gastrointestinal drugs market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global gastrointestinal drugs market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca plc
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Allergan Plc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Eisai Co., Ltd.
  • GlaxoSmithKline Plc.
  • Janssen Biotech Inc.
  • Janssen Biotech, Inc.
  • Sanofi S.A
  • Takeda Pharmaceutical Company Limited
  • ZERIA Pharmaceutical Co.,Ltd.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Gastrointestinal Drugs Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL GASTROINTESTINAL DRUGS MARKET, BY DRUG CATEGORY
    • Acid Neutralizers
    • Anti-Inflammatory
    • Antiemetic and Antinauseants
    • Biologics
    • Laxatives and Anti-diarrheal
  • GLOBAL GASTROINTESTINAL DRUGS MARKET, BY ROUTE OF ADMINISTRATION
    • Oral
    • Parenteral
    • Rectal
  • GLOBAL GASTROINTESTINAL DRUGS MARKET, BY DISEASE TYPE
    • Gastroesophageal Reflux Disorder
    • Irritable Bowel Syndrome
  • GLOBAL GASTROINTESTINAL DRUGS MARKET, BY END USER
    • Hospital Pharmacies
    • Retail Pharmacies
  • GLOBAL GASTROINTESTINAL DRUGS MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • South Korea
      • Thailand
    • Europe, Middle East & Africa
      • Denmark
      • France
      • Germany
      • Italy
      • Netherlands
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • United Arab Emirates
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Gastrointestinal Drugs Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Gastrointestinal Drugs Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Gastrointestinal Drugs Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Gastrointestinal Drugs Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Gastrointestinal Drugs Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Gastrointestinal Drugs Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Gastrointestinal Drugs Market .
  • Evaluate the key vendors in the Global Gastrointestinal Drugs Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Market Data Feed
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increasing geriatric population, changing lifestyles and eating habits
        2. Development in biologics and a rising number of rectal related diseases
        3. Drug development and rising awareness
      2. Restraints
        1. Side effects associated with the drugs
      3. Opportunities
        1. R&D activities to enhance drug development
        2. Technological advancements in the treatment process
      4. Challenges
        1. Unavailable permanent cure for diseases such as inflammatory bowel disease and Irritable bowel syndrome
    3. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Client Customizations
  5. Global Gastrointestinal Drugs Market, by Drug Category
    1. Overview
    2. Market Sizing & Forecasting
    3. Acid Neutralizers
    4. Anti-Inflammatory
    5. Antiemetic and Antinauseants
    6. Biologics
    7. Laxatives and Anti-diarrheal
  6. Global Gastrointestinal Drugs Market, by Route of Administration
    1. Overview
    2. Market Sizing & Forecasting
    3. Oral
    4. Parenteral
    5. Rectal
  7. Global Gastrointestinal Drugs Market, by Disease Type
    1. Overview
    2. Market Sizing & Forecasting
    3. Gastroesophageal Reflux Disorder
    4. Irritable Bowel Syndrome
  8. Global Gastrointestinal Drugs Market, by End User
    1. Overview
    2. Market Sizing & Forecasting
    3. Hospital Pharmacies
    4. Retail Pharmacies
  9. Global Gastrointestinal Drugs Market, by Geography
    1. Overview
    2. Market Sizing & Forecasting
    3. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Chile
      5. Mexico
      6. United States
    4. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    5. Europe, Middle East & Africa
      1. Denmark
      2. France
      3. Germany
      4. Italy
      5. Netherlands
      6. Qatar
      7. Russia
      8. Saudi Arabia
      9. South Africa
      10. Spain
      11. United Arab Emirates
      12. United Kingdom
  10. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
        1. Forefront
        2. Pathfinders
        3. Niche
        4. Vital
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  11. Company Usability Profiles
    1. AbbVie Inc.
      1. Overview
      2. Strategy
      3. SWOT
    2. Abbott Laboratories
      1. Overview
      2. Strategy
      3. SWOT
    3. AstraZeneca plc
      1. Overview
      2. Strategy
      3. SWOT
    4. Bausch Health Companies Inc.
      1. Overview
      2. Strategy
      3. SWOT
    5. Johnson & Johnson
      1. Overview
      2. Strategy
      3. SWOT
    6. Allergan Plc
    7. Bayer AG
    8. Boehringer Ingelheim GmbH
    9. Eisai Co., Ltd.
    10. GlaxoSmithKline Plc.
    11. Janssen Biotech Inc.
    12. Janssen Biotech, Inc.
    13. Sanofi S.A
    14. Takeda Pharmaceutical Company Limited
    15. ZERIA Pharmaceutical Co.,Ltd.
  12. Appendix
    1. Discussion Guide
    2. Author Details

List of Tables

  1. GLOBAL GASTROINTESTINAL DRUGS MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  4. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ACID NEUTRALIZERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ANTIEMETIC AND ANTINAUSEANTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY LAXATIVES AND ANTI-DIARRHEAL, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  10. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY PARENTERAL, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  14. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISORDER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  17. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  19. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  20. AMERICAS GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  21. AMERICAS GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  22. AMERICAS GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  23. AMERICAS GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  24. ARGENTINA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  25. ARGENTINA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  26. ARGENTINA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  27. ARGENTINA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  28. BRAZIL GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  29. BRAZIL GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  30. BRAZIL GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  31. BRAZIL GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  32. CANADA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  33. CANADA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  34. CANADA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  35. CANADA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  36. CHILE GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  37. CHILE GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  38. CHILE GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  39. CHILE GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  40. MEXICO GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  41. MEXICO GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  42. MEXICO GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  43. MEXICO GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  44. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  45. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  46. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  47. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  48. ASIA-PACIFIC GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  49. ASIA-PACIFIC GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  50. ASIA-PACIFIC GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  51. ASIA-PACIFIC GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  52. AUSTRALIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  53. AUSTRALIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  54. AUSTRALIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  55. AUSTRALIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  56. CHINA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  57. CHINA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  58. CHINA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  59. CHINA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  60. INDIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  61. INDIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  62. INDIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  63. INDIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  64. INDONESIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  65. INDONESIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  66. INDONESIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  67. INDONESIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  68. JAPAN GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  69. JAPAN GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  70. JAPAN GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  71. JAPAN GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  72. MALAYSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  73. MALAYSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  74. MALAYSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  75. MALAYSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  76. PHILIPPINES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  77. PHILIPPINES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  78. PHILIPPINES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  79. PHILIPPINES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  80. SOUTH KOREA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  81. SOUTH KOREA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  82. SOUTH KOREA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  83. SOUTH KOREA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  84. THAILAND GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  85. THAILAND GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  86. THAILAND GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  87. THAILAND GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  88. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  89. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  90. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  91. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  92. DENMARK GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  93. DENMARK GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  94. DENMARK GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  95. DENMARK GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  96. FRANCE GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  97. FRANCE GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  98. FRANCE GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  99. FRANCE GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  100. GERMANY GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  101. GERMANY GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  102. GERMANY GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  103. GERMANY GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  104. ITALY GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  105. ITALY GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  106. ITALY GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  107. ITALY GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  108. NETHERLANDS GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  109. NETHERLANDS GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  110. NETHERLANDS GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  111. NETHERLANDS GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  112. QATAR GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  113. QATAR GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  114. QATAR GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  115. QATAR GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  116. RUSSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  117. RUSSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  118. RUSSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  119. RUSSIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  120. SAUDI ARABIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  121. SAUDI ARABIA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  122. SAUDI ARABIA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  123. SAUDI ARABIA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  124. SOUTH AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  125. SOUTH AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  126. SOUTH AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  127. SOUTH AFRICA GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  128. SPAIN GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  129. SPAIN GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  130. SPAIN GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  131. SPAIN GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  132. UNITED ARAB EMIRATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  133. UNITED ARAB EMIRATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  134. UNITED ARAB EMIRATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  135. UNITED ARAB EMIRATES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  136. UNITED KINGDOM GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2016-2025 (USD MILLION)
  137. UNITED KINGDOM GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2016-2025 (USD MILLION)
  138. UNITED KINGDOM GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2016-2025 (USD MILLION)
  139. UNITED KINGDOM GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  140. GLOBAL GASTROINTESTINAL DRUGS MARKET: RANKING
  141. GLOBAL GASTROINTESTINAL DRUGS MARKET: AUTHOR DETAILS

List of Figures

  1. GLOBAL GASTROINTESTINAL DRUGS MARKET: RESEARCH PROCESS
  2. GLOBAL GASTROINTESTINAL DRUGS MARKET: RESEARCH FRAMEWORK
  3. GLOBAL GASTROINTESTINAL DRUGS MARKET: FORECASTING METHODOLOGY
  4. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL GASTROINTESTINAL DRUGS MARKET: MARKET CONNECTIVITY
  6. GLOBAL GASTROINTESTINAL DRUGS MARKET: MARKET DYNAMICS
  7. GLOBAL GASTROINTESTINAL DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  8. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2018 VS 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2025 (USD MILLION)
  10. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 (USD MILLION)
  12. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2018 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2025 (USD MILLION)
  14. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2018 VS 2025 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2025 (USD MILLION)
  16. GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GASTROINTESTINAL DRUGS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  18. GLOBAL GASTROINTESTINAL DRUGS MARKET: FPNV POSITIONING MATRIX
  19. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL GASTROINTESTINAL DRUGS MARKET, BY NEWS TYPE
  20. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL GASTROINTESTINAL DRUGS MARKET, BY COMPANY
  21. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL GASTROINTESTINAL DRUGS MARKET, BY YEAR
  1. Abbott Laboratories
  2. AbbVie Inc.
  3. AstraZeneca plc
  4. Bausch Health Companies Inc.
  5. Johnson & Johnson
  6. Allergan Plc
  7. Bayer AG
  8. Boehringer Ingelheim GmbH
  9. Eisai Co., Ltd.
  10. GlaxoSmithKline Plc.
  11. Janssen Biotech Inc.
  12. Janssen Biotech, Inc.
  13. Sanofi S.A
  14. Takeda Pharmaceutical Company Limited
  15. ZERIA Pharmaceutical Co.,Ltd.
Global Gastrointestinal Drugs Market
Report Code
PH-DA051D2
Publishing Date
August 2019
Number of Pages
104
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $5449
CORPORATE USER LICENSE $4449
SINGLE USER LICENSE $3449
WEB PACK LICENSE $2949
DATA PACK LICENSE $1749

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.